19106, Philadelphia, Pennsylvania Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 19106, Philadelphia, Pennsylvania is 93 when comparing 34,000 ZIP Codes in the United States.

An estimate of 89.02 percent of the residents in 19106 has some form of health insurance. 21.65 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 82.11 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 19106 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 818 residents under the age of 18, there is an estimate of 514 pediatricians in a 20-mile radius of 19106. An estimate of 119 geriatricians or physicians who focus on the elderly who can serve the 2,750 residents over the age of 65 years.

In a 20-mile radius, there are 108,529 health care providers accessible to residents in 19106, Philadelphia, Pennsylvania.

**Prostate Cancer Score Analysis: Philadelphia (ZIP Code 19106)**

This analysis delves into the landscape of prostate cancer care within Philadelphia's 19106 ZIP code, a region encompassing a significant portion of Center City. We will evaluate factors influencing patient access to care, the quality of available resources, and the overall prognosis for individuals diagnosed with prostate cancer. This assessment considers physician-to-patient ratios, standout practices, telemedicine adoption, and the integration of mental health support, ultimately providing a Prostate Cancer Score.

The foundation of effective prostate cancer management rests upon the availability of skilled medical professionals. Physician-to-patient ratios are a crucial metric. In 19106, the concentration of medical institutions, including hospitals and specialist practices, suggests a relatively favorable physician-to-patient ratio compared to other areas of Philadelphia. However, this advantage can be offset by factors like insurance acceptance, specialist availability, and the geographic distribution of patients within the ZIP code. Further research into the specific number of urologists and oncologists specializing in prostate cancer care within the area is essential for a precise evaluation.

Several medical practices within and around 19106 are recognized for their excellence in prostate cancer treatment. Institutions like the Hospital of the University of Pennsylvania (HUP) and Thomas Jefferson University Hospitals offer comprehensive services, including advanced diagnostic tools (MRI, PET scans), minimally invasive surgical techniques (robotic-assisted prostatectomy), and radiation therapy options. Their multidisciplinary approach, involving urologists, oncologists, radiation oncologists, and support staff, is a key indicator of quality. These institutions often participate in clinical trials, providing patients access to cutting-edge treatments and research opportunities.

The adoption of telemedicine has significantly impacted healthcare delivery, especially for chronic conditions like prostate cancer. In 19106, telemedicine offers the potential to improve access to care, reduce travel burdens, and facilitate remote monitoring. Many practices now offer virtual consultations for follow-up appointments, medication management, and patient education. This is particularly beneficial for patients with mobility issues or those living outside of the immediate vicinity of major hospitals. The extent of telemedicine adoption varies among practices; a thorough evaluation should consider the availability of virtual appointments, the ease of use of the platforms, and the integration of remote monitoring technologies.

Prostate cancer diagnosis and treatment can have a profound impact on a patient's mental and emotional well-being. The availability of mental health resources is a critical component of comprehensive care. Within 19106, patients should have access to psychologists, psychiatrists, and support groups specializing in cancer-related issues. Major hospitals often have dedicated oncology social workers who provide counseling, support, and referrals to relevant resources. Assessing the integration of mental health services into the overall care plan, the availability of support groups, and the accessibility of mental health professionals are essential aspects of the Prostate Cancer Score.

Beyond the core medical services, several factors contribute to the overall quality of care. The availability of patient education materials, support groups, and financial assistance programs are crucial. The integration of these resources into the patient's care plan demonstrates a commitment to holistic care. Furthermore, the use of electronic health records (EHRs) and the seamless exchange of information between different specialists are important indicators of efficiency and coordination of care.

Evaluating the Prostate Cancer Score requires a multi-faceted approach. This analysis considers the physician-to-patient ratio, the quality of standout practices, the adoption of telemedicine, and the integration of mental health resources. The score would also factor in the availability of patient education materials, support groups, and financial assistance programs. A comprehensive evaluation would involve gathering data from various sources, including medical institutions, patient surveys, and public health records.

The specific score for 19106 would be based on the weighted average of these factors. A high score would indicate a favorable environment for prostate cancer care, with readily available specialists, advanced treatment options, robust telemedicine capabilities, and comprehensive mental health support. A lower score would highlight areas for improvement, such as limited access to specialists, inadequate telemedicine infrastructure, or a lack of mental health resources.

The analysis also needs to consider primary care availability in Philadelphia, as a whole. Primary care physicians (PCPs) play a crucial role in early detection and referral for prostate cancer. The overall availability of PCPs in Philadelphia, including those accepting new patients and those with expertise in men's health, directly impacts the timely diagnosis and treatment of prostate cancer. Areas with limited access to primary care may experience delayed diagnoses, leading to poorer outcomes. Assessing the PCP-to-patient ratio, the geographic distribution of PCPs, and the availability of preventive care services are essential components of this assessment.

In conclusion, the Prostate Cancer Score for 19106, and the broader assessment of primary care availability in Philadelphia, is a dynamic measure reflecting the quality and accessibility of care. This analysis provides a framework for understanding the strengths and weaknesses of the local healthcare landscape, ultimately aiming to improve outcomes for individuals diagnosed with prostate cancer.

**For a visual representation of the healthcare landscape in 19106 and throughout Philadelphia, including the distribution of medical facilities, physician density, and access to care, we encourage you to explore the interactive maps provided by CartoChrome. These maps offer valuable insights into the spatial distribution of healthcare resources, helping you to make informed decisions about your health.**